ALB and hypercalcemia disease: Her albumin-adjusted [Ca] of 2.61 mmol/L declined to 2.39 mmol/L in a repeat specimen on the same day, the illness was self-limited, and there was no other biochemical or clinical evidence of vitamin D toxicity; furthermore, the participant continued to receive the supplement and had increasing [25(OH)D] (range, 52 to 98 nmol/L during follow-up) but did not develop any further episodes of hypercalcemia or elevations in urine ca:cr.